The 5-year survival (Table I ) decreased steadily with both increasing stage (Langlands & Kerr, 1978) and grade (Freedman et al., 1979) . Tumour size increased with increasing grade (I, 2*4cm+ 1 4; II, 3 0 cm+ 1-4; JII,3A4 cm+ 1.6) in keeping with Fisher et al. (1980) .
The main finding here (Table II) Breaking up the grades into 3 different factors (Table III) showed that Factor 2 (hyperchromatism and mitosis) was the most important for prognosis, especially in Stages I and II. The association of hyperchromatism and mitosis with highgrade tumours, and its further association with advanced stage at presentation is logical, as the intrinsic rate of progress of tumours of this type is high. This has been shown previously in the relationship to survival time after presentation. It is thus not surprising that this should have had similar influence in the preclinical phase. This goes far to explain the rationale behind Shimkin's (1969) statement that "the overwhelming single determinant of prognosis is the stage of the disease at initial definitive treatment".
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